Your institution may have access to this item. Find your institution then sign in to continue.
Title
Deferiprone (GPO-L-ONE<sup>®</sup>) monotherapy reduces iron overload in transfusion-dependent thalassemias: 1-year results from a multicenter prospective, single arm, open label, dose escalating phase III pediatric study (GPO-L-ONE; A001) from Thailand